IVF Live Birth Rates at 35, 38, and 41: How to Read SART Clinic Data Before Committing to a $25K Cycle
IVF Live Birth Rates at 35, 38, and 41: How to Read SART Clinic Data Before Committing to a $25K Cycle
You've been quoted $18K–$25K for an IVF cycle, and the clinic's website says something like "65% success rate." You nod. You feel cautiously hopeful. Then you get home and start Googling — and you realize you have absolutely no idea what that number means, whether it applies to you, or whether the clinic next door is meaningfully different.
Here's the thing: that "65% success rate" might be a pregnancy rate, not a live birth rate. It might be for patients under 35 using donor eggs. It might exclude cycles that were cancelled before retrieval — which is where a lot of the real information lives.
SART (the Society for Assisted Reproductive Technology) publishes detailed outcome data for every reporting clinic in the U.S. It's genuinely valuable. It's also genuinely confusing — even for patients who've already been through one or two cycles. This post is about how to read it for your age, your diagnosis, and the actual question you're trying to answer: What are the realistic odds that THIS clinic gets me to a live birth, and how does that change if I do one cycle versus three?
Why the Number on the Clinic's Website Is Almost Certainly Wrong for You
Let's start with the most important distinction: pregnancy rate versus live birth rate.
A positive beta HCG is a pregnancy. A baby going home from the hospital is a live birth. The gap between those two outcomes is not small — across all age groups, the SART 2021 national data shows a meaningful dropout between clinical pregnancy rates and live birth rates, especially as patient age increases. Clinics that advertise "success rates" without specifying which metric they're using are almost always showing you the more optimistic number.
The second issue is per-retrieval versus per-transfer reporting. A clinic with a 45% live birth rate per transfer sounds great. But if they cancel 30% of cycles before retrieval due to poor response, and transfer only their best-looking cases, the real picture is much bleaker for a patient who walks in the door.
Per-intended-retrieval is the most honest number — it captures everyone who started a cycle, including patients whose cycles were cancelled. It's harder to find and lower than the headline stat. Always ask for it.
What SART Data Actually Shows: A Breakdown by Age
SART's 2021 national summary data (the most recent complete reporting cycle) breaks down live birth rates per egg retrieval by age bracket. Here's what those numbers look like — and what they mean in dollars:
| Age Bracket | Avg. Live Birth Rate/Retrieval | Est. Total Cost Per Cycle* | Cost Per Live Birth (1 cycle) |
|---|---|---|---|
| Under 35 | ~42% | $25,000 | ~$59,500 |
| 35–37 | ~32% | $25,000 | ~$78,100 |
| 38–40 | ~22% | $25,000 | ~$113,600 |
| 41–42 | ~11% | $25,000 | ~$227,300 |
| 43–44 | ~5% | $25,000 | ~$500,000+ |
*Includes medications ($4K–$7K), monitoring, PGT-A, and one FET. See IVF cycle planning and total cost breakdown for a full model.
These are national averages. The variation between clinics for the same age bracket can be 10–18 percentage points — which means the difference between a 22% clinic and a 38% clinic at age 40 is the difference between needing 4–5 cycles and needing 2–3. At $25K per cycle, that's $50,000–$75,000 riding on which clinic you choose.
This is the kind of analysis Feralyx runs for you — so you don't have to build the spreadsheet yourself.
The Cumulative Success Calculation Clinics Never Show You
A single IVF cycle has a specific probability of live birth. But most patients go through more than one cycle — which means the question you actually need to answer is: What is my probability of a live birth after 2 or 3 cycles at this clinic?
The math is simple once you have it:
Cumulative live birth probability = 1 − (1 − per-cycle rate)^n
Where n = number of cycles.
Worked Example: Age 38, Two Different Clinics
Let's say you're 38 years old. Clinic A reports a 22% live birth rate per retrieval. Clinic B reports 34%. Here's how that plays out over three cycles:
| Cycles Attempted | Clinic A (22%/cycle) | Clinic B (34%/cycle) |
|---|---|---|
| 1 cycle | 22% | 34% |
| 2 cycles | 39% | 56% |
| 3 cycles | 52% | 71% |
| Total cost (3 cycles) | ~$75,000 | ~$75,000 |
Same cost. Dramatically different probability of going home with a baby.
The 12-percentage-point gap between clinics per cycle compounds into a 19-point gap in cumulative success after three cycles. And yet most patients don't calculate this — they look at the per-cycle number, pick a clinic based on proximity or referral, and commit tens of thousands of dollars without running these numbers.
You can model this for your specific age, diagnosis, and cycle count at Feralyx.
The Three Ways Clinics Cherry-Pick Their Statistics
Before you trust any clinic's published success rate, you need to know these three manipulation tactics. They're legal, they're common, and they make mediocre clinics look great on paper.
1. High Cancellation Rates That Disappear from Reporting
If a clinic cancels 25% of cycles before retrieval — because your follicle count was low, or your estrogen wasn't rising fast enough — those patients often vanish from the "per retrieval" denominator. The clinic's success rate looks great because they only count cycles where they retrieved eggs from good responders.
What to look for: Ask your clinic directly what their cancellation rate is. SART reports this, but it's buried. A cancellation rate above 15–20% for patients in your age bracket should prompt a direct question about how their headline rate is calculated.
2. Reporting Pregnancy Rates as Success Rates
As covered above, pregnancy rates (positive beta HCG or clinical pregnancy confirmed at 6–7 weeks) are substantially higher than live birth rates. The national gap between clinical pregnancy and live birth is roughly 8–12 percentage points on average, and wider in older age groups where pregnancy loss rates are higher.
Always confirm: Is this a live birth rate or a pregnancy rate?
3. Mixing Donor Egg Cycles Into Own-Egg Statistics
Donor egg IVF has live birth rates of 45–55% regardless of recipient age, because the egg quality reflects the donor's age (typically under 30). A clinic that serves a high proportion of donor egg patients will have aggregate success rates that look dramatically better than their own-egg outcomes.
SART does break down donor versus autologous (own-egg) cycles — but clinics are under no obligation to surface that distinction in their marketing. Ask specifically: "What is your live birth rate per retrieval for autologous cycles in my age bracket?"
What AMH and AFC Tell You About YOUR Odds (Not the Clinic's)
Two numbers from your workup fundamentally shape your expected outcomes at any clinic:
AMH (Anti-Müllerian Hormone): A blood test that reflects your ovarian reserve — roughly, how many eggs your ovaries have left. An AMH under 1.0 ng/mL is considered low; under 0.5 is very low. Low AMH doesn't mean IVF can't work, but it does mean your expected egg yield per retrieval is lower, which affects both success rates and the value of banking multiple cycles.
AFC (Antral Follicle Count): An ultrasound count of small resting follicles, which predicts how many eggs you're likely to produce in a stimulated cycle. An AFC under 7 is considered low. Like AMH, it's not a binary outcome predictor — but it's a key input into any realistic probability estimate.
If your AMH is low and your AFC is low, a clinic's average success rate for your age bracket will overstate your personal probability. Conversely, if your ovarian reserve markers are strong for your age, average rates may understate your odds.
This is why the SART data is necessary but not sufficient. You need clinic-level data filtered to patients with your profile — which is exactly the gap that makes comparing clinics so hard without a tool designed to do it.
PGT-A: Does It Improve Your Odds or Just Tell You What Would Have Failed Anyway?
PGT-A (Preimplantation Genetic Testing for Aneuploidies) — the test that checks whether embryos have the correct number of chromosomes — adds $3,000–$6,000 to your cycle cost. Whether it improves your live birth rate per cycle depends heavily on your age.
For patients under 35, the majority of embryos are chromosomally normal anyway, and the evidence that PGT-A improves live birth rates in this group is mixed. For patients 38 and over, the proportion of aneuploid embryos rises sharply (50–70% in the 40–42 range), and PGT-A can meaningfully reduce the risk of a failed transfer or miscarriage by identifying viable embryos upfront.
What PGT-A definitely does: It reduces the number of transfers you need before a live birth, which reduces the time and emotional toll — even if the cumulative probability of success after all tested embryos are transferred isn't dramatically different from untested transfer.
What it doesn't do: Improve egg quality or create viable embryos that weren't there. A cycle that produces two blastocysts, both aneuploid, ends the same way whether or not you tested them.
If you're over 38 and considering whether PGT-A is worth the $4,000 add-on, the calculus usually favors testing — but run your specific numbers. At Feralyx, you can model cost-per-live-birth with and without PGT-A for your age bracket and expected embryo yield.
The Comparison You Should Make Before Your Next Cycle
If you're evaluating clinics or deciding whether to return to the same one, here's the minimum data you need:
- Live birth rate per intended retrieval (not per transfer, not per pregnancy) for your age bracket and cycle type (autologous vs. donor)
- Cancellation rate for patients in your profile
- Cumulative live birth rate across 2–3 cycles — if they don't have this, calculate it yourself using the formula above
- PGT-A utilization and tested-embryo transfer success rates for your age group
- Total out-of-pocket cost including meds, monitoring, PGT, and the FET you'll likely need — not just the base cycle quote
On the financial side, if you're modeling whether a shared-risk/refund program makes sense given your age and expected success probability, the break-even analysis looks very different at 36 than at 41. We've covered the math on IVF refund programs versus pay-per-cycle here.
And if you're still figuring out what your insurance will actually cover before you commit to any of this, the state mandate and ERISA landscape is more complicated than most patients realize.
The Bottom Line
A clinic's headline success rate is a starting point, not an answer. The real question — what are my cumulative odds of a live birth across the cycles I can realistically afford, at the clinics within reach, given my specific age and diagnosis — requires you to combine SART data, your own lab results, your expected total cost, and a probability model that compounds across cycles.
That is not a calculation most patients have time to build from scratch while also navigating the emotional weight of fertility treatment. You shouldn't have to.
Feralyx was built for exactly this: to give you the clinic comparison, cost model, and cumulative success probability you need before committing to another cycle — using your numbers, not national averages.
Because the difference between the right clinic and the wrong one isn't just statistical. At $25K per cycle, it's everything.
Sources
- ‘They Tricked Me’: A Father Was Chained After He Went to ICE To Reunite With His Kids — KFF Reproductive Health
- Listen to the Latest ‘KFF Health News Minute’ — KFF Reproductive Health
- “Me engañaron”: agentes encadenan a un padre que había ido al ICE a reunirse con sus hijos — KFF Reproductive Health
- CommonSpirit, Humana reach new nationwide Medicare Advantage contract — Healthcare Dive
- Cencora to buy EyeSouth’s retina business for $1.1B — Healthcare Dive